Healios
4593.TTSE GROWTHPharmaceutical
Major holders (5%+) · 3
| Holder | Stake |
|---|---|
| Athos Capital Limited | 30.52% |
| Tadahisa Kagimoto | 28.19% |
| Morgan Stanley & Co. International plc | 7.15% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 5
| Maven Investment Partners Ltd | 4.71% |
| Heights Capital Management, Inc. | 4.45% |
| FIL Investments (Japan) Limited | 3.25% |
| Morgan Stanley MUFG Securities Co., Ltd. | 0.11% |
| Morgan Stanley & Co. LLC | 0.00% |
Ownership history · 47
| Holder | Ratio | Change |
|---|---|---|
| Morgan Stanley & Co. International plc2024-09-05 · amended | 8.05% | +0.72pp |
| Morgan Stanley & Co. International plc2024-09-05 · amended | 7.33% | +0.75pp |
| Morgan Stanley & Co. International plc2024-09-05 · amended | 6.58% | -0.38pp |
| Morgan Stanley & Co. International plc2024-09-05 · amended | 6.96% | new |
| Athos Capital Limited2024-02-19 · amended | 31.47% | no change |
| Athos Capital Limited2024-02-19 · amended | 31.47% | new |
| Heights Capital Management, Inc.2024-02-09 · amended | 4.45% | new |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.